Pharmacokinetics of voriconazole and cytochrome P450 2C19 genetic status

被引：129
|
作者：
Ikeda, Y [1 ]
Umemura, K
Kondo, K
Sekiguchi, K
Nakashima, M
机构：
[1] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 43131, Japan
[2] Pfizer Japan Inc, Tokyo, Japan
[3] Hamamatsu Inst Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka, Japan
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2004年 / 75卷 / 06期
关键词：
D O I：
10.1016/j.clpt.2004.02.002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：587 / 588
页数：2
相关论文
共 50 条
  • [31] Development of PNA-Array Platforms for Detection of Genetic Polymorphism of Cytochrome P450 2C19
    Hong, Daewha
    Park, Hyung Ju
    Chi, Young Shik
    Lee, Young
    Lee, Juno
    Kang, Hyo Jin
    Park, Dae Keun
    Chung, Sang J.
    Yun, Wan Soo
    Choi, Insung S.
    [J]. BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2011, 32 (08) : 2895 - 2896
  • [32] A rapid and simple detection of genetic defects responsible for the phenotypic polymorphism of cytochrome P450 2C19
    Itoh, K
    Inoue, K
    Yanagiwara, S
    Kyoya, H
    Suzuki, T
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1999, 22 (01) : 77 - 79
  • [33] The Structure of Human Cytochrome P450 2C19: Active site differences between P450s 2C19 and 2C9
    Reynald, Rosamund L.
    Sansen, Stefaan
    Stout, C. David
    Johnson, Eric F.
    [J]. FASEB JOURNAL, 2008, 22
  • [34] Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China
    Yang, Z. F.
    Cui, H. W.
    Hasi, T.
    Jia, S. Q.
    Gong, M. L.
    Su, X. L.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2010, 9 (03) : 1844 - 1851
  • [35] Association between genetic polymorphisms of cytochrome P450 2C19 and the risk of cerebral ischemic stroke in Chinese
    Gu, Shuzhen
    Sun, Yan
    Han, Ruifa
    Wang, Lin
    Wang, Dongliang
    Wang, Jizuo
    Li, Xin
    [J]. BMC MEDICAL GENETICS, 2014, 15
  • [36] Expression and Functional Analysis of Human Cytochrome P450 2C19 Polymorphic Alleles
    Wang, Hui-Juan
    Gao, Yi-Wen
    Ma, Ping-Ping
    Zhu, Juan-Li
    Chen, Chao
    [J]. DRUG METABOLISM REVIEWS, 2009, 41 : 39 - 40
  • [37] Correlation between cytochrome P450 2C19 genetic polymorphism and treatment response to escitalopram in panic disorder
    He, Qianqian
    Yuan, Zhuo
    Liu, Yuanyuan
    Zhang, Jian
    Yan, Hong
    Shen, Li
    Luo, Xingguang
    Zhang, Yong
    [J]. PHARMACOGENETICS AND GENOMICS, 2017, 27 (08): : 279 - 284
  • [38] Nanogap-Based Electrical PNA Chips for the Detection of Genetic Polymorphism of Cytochrome P450 2C19
    Park, Dae Keun
    Park, Hyung Ju
    Lee, Cho Yeon
    Hong, Daewha
    Lee, Young
    Choi, Insung S.
    Yun, Wan Soo
    [J]. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2012, 12 (07) : 5155 - 5159
  • [39] Cytochrome P450 2C19 polymorphism in Iranian patients with coronary artery disease
    Akhlaghi, Arash
    Shirani, Shahin
    Ziaie, Naghmeh
    Pirhaji, Omid
    Yaran, Majid
    Shahverdi, Golnoosh
    Sarrafzadegan, Nizal
    Khosravi, Alireza
    Khosravi, Elham
    [J]. ARYA ATHEROSCLEROSIS, 2011, 7 (03) : 106 - 110
  • [40] The antiepileptic efficacy of stiripentol is not exclusively be depending on the inhibition of the cytochrome P450 2C19
    Chhun, S.
    Nabbout, R.
    Salem, J.
    Rey, E.
    Dulac, O.
    Pons, G.
    Chiron, C.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 74 - 74
12345